Plastic bottles transformed into Parkinson's drug using bacteria
Why it matters: Turning plastic waste into life‑saving medicine cuts pollution while slashing drug‑production emissions.
- University of Edinburgh engineered E. coli to transform PET into L‑DOPA (per Nature Sustainability).
- Carbon‑Loop Sustainable Biomanufacturing Hub supplied £14 m funding and a testbed for scaling the process.
- EPSRC/UKRI backs the work, underscoring national priority for circular‑economy chemistry.
- Traditional L‑DOPA synthesis depends on fossil‑fuel feedstocks; the new method cuts waste and emissions.
- Future outlook targets industrial scale, potentially expanding to other chemicals, flavorings, and cosmetics.
University of Edinburgh researchers have reprogrammed E. coli to convert PET plastic waste into L‑DOPA, a frontline Parkinson’s drug, demonstrating a sustainable bio‑upcycling route that could reshape pharmaceutical manufacturing.
